Market closed

Procaps Group/$PROC

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Procaps Group

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Ticker

$PROC
Trading on

Industry

Pharmaceuticals

Headquarters

Luxembourg, Luxembourg

Employees

5,500

Procaps Group Metrics

BasicAdvanced
$283M
Market cap
4.89
P/E ratio
$0.51
EPS
-
Beta
-
Dividend rate
$283M
$4.95
$0.50
191K
1.47
0.929
573.886
753.94
1.28%
6.28%
373.70%
4.894
0.616
6.53
-33.31
7.49
-4.80%
-13.40%

What the Analysts think about Procaps Group

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Procaps Group stock.

Procaps Group Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Procaps Group Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PROC

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Procaps Group stock?

Procaps Group (PROC) has a market cap of $283M as of December 22, 2024.

What is the P/E ratio for Procaps Group stock?

The price to earnings (P/E) ratio for Procaps Group (PROC) stock is 4.89 as of December 22, 2024.

Does Procaps Group stock pay dividends?

No, Procaps Group (PROC) stock does not pay dividends to its shareholders as of December 22, 2024.

When is the next Procaps Group dividend payment date?

Procaps Group (PROC) stock does not pay dividends to its shareholders.

What is the beta indicator for Procaps Group?

Procaps Group (PROC) does not currently have a Beta indicator.